SEARCH

SEARCH BY CITATION

References

  • Adam-Vizi V. and Starkov A. A. (2010) Calcium and mitochondrial reactive oxygen species generation: how to read the facts. J. Alzheimers Dis. 20(Suppl 2), S413S426.
  • Agostinho F. R., Jornada L. K., Schröder N., Roesler R., Dal-Pizzol F. and Quevedo J. (2007) Effects of chronic haloperidol and/or clozapine on oxidative stress parameters in rat brain. Neurochem. Res. 32, 13431350.
  • Agostinho F. R., Réus G. Z., Stringari R. B., Ribeiro K. F., Pfaffenseller B., Stertz L., Panizzutti B. S., Kapczinski F. and Quevedo J. (2011) Olanzapine plus fluoxetine treatment increases Nt-3 protein levels in the rat prefrontal cortex. Neurosci. Lett. 497, 99103.
  • Altamura A. C., Serati M., Albano A., Paoli R. A., Glick I. D. and Dell'Osso B. (2011) An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. Eur. Arch. Psychiatry Clin. Neurosci. 261, 489508.
  • Andreazza A. C. (2012) Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders. Mol. BioSyst. 8, 25032512.
  • Andreazza A. C., Cassini C., Rosa A. R. et al. (2007) Serum S100B and antioxidant enzymes in bipolar patients. J. Psychiatr. Res. 41, 523529.
  • Andreazza A. C., Kauer-Sant'anna M., Frey B. N., Bond D. J., Kapczinski F., Young L. T. and Yatham L. N. (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect. Disord. 111, 135144.
  • Andreazza A. C., Kapczinski F., Kauer-Sant'Anna M., Walz J. C., Bond D. J., Goncalves C. A., Young L. T. and Yatham L. N. (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 34, 263271.
  • Andreazza A. C., Shao L., Wang J. F. and Young L. T. (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 67, 360368.
  • Andreazza A. C. and Young L. T. (2013) The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int. J. Neuropsychopharmacol. 1, 114.
  • Banigan M. G., Kao P. F., Kozubek J. A. et al. (2013) Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE 8, e48814.
  • Beal M. F. (2002) Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32, 797803.
  • Beckman J. S. and Koppenol W. H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424C1437.
  • Berk M., Dodd S., Kauer-Sant'anna M., Malhi G. S., Bourin M., Kapczinski F. and Norman T. (2007) Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. Suppl. 433, 4149.
  • Berk M., Kapczinski F., Andreazza A. C. et al. (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35, 804817.
  • Bongarzone E. R., Pasquini J. M. and Soto E. F. (1995) Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J. Neurosci. Res. 41, 213221.
  • Brenner-Lavie H., Klein E., Zuk R., Gazawi H., Ljubuncic P. and Ben-Shachar D. (2008) Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia. Biochim. Biophys. Acta 1777, 173185.
  • Clay H. B., Sillivan S. and Konradi C. (2010) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29, 311324.
  • Crecelius A., Götz A., Arzberger T., Fröhlich T., Arnold G. J., Ferrer I. and Kretzschmar H. A. (2008) Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE. Proteomics 8, 12761291.
  • Dalle-Donne I., Giustarini D., Colombo R., Rossi R. and Milzani A. (2003) Protein carbonylation in human diseases. Trends Mol. Med. 9, 169176.
  • Dietrich-Muszalska A., Malinowska J., Olas B., Głowacki R., Bald E., Wachowicz B. and Rabe-Jabłońska J. (2012) The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem. Res. 37, 10571062.
  • Dunkley P. R., Jarvie P. E. and Robinson P. J. (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat. Protoc. 3, 17181728.
  • Frey B. N., Andreazza A. C., Houenou J. et al. (2013) Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force. Aust. N. Z. J. Psychiatry 47(4), 321332.
  • García-Heredia J. M., Díaz-Moreno I., Nieto P. M., Orzáez M., Kocanis S., Teixeira M., Pérez-Payá E., Díaz-Quintana A. and De la Rosa M. A. (2010) Nitration of tyrosine 74 prevents human cytochrome c to play a key role in apoptosis signaling by blocking caspase-9 activation. Biochim. Biophys. Acta 1797, 981993.
  • Gigante A. D., Young L. T., Yatham L. N., Andreazza A. C., Nery F. G., Grinberg L. T., Heinsen H. and Lafer B. (2010) Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14, 10751089.
  • Goldstein B. I., Fagiolini A., Houck P. and Kupfer D. J. (2009) Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord. 11, 657662.
  • Green D. R. and Kroemer G. (2004) The pathophysiology of mitochondrial cell death. Science 305, 626629.
  • Grune T., Reinheckel T. and Davies K. J. (1996) Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem. 271, 1550415509.
  • Grune T., Reinheckel T. and Davies K. J. (1997) Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526534.
  • Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 16091623.
  • Halliwell B. (2006) Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97, 16341658.
  • Halliwell B. and Gutteridge J. M. (1984) Free radicals, lipid peroxidation, and cell damage. Lancet 2, 1095.
  • Halliwell B. and Gutteridge J. M. C. (2007) Free Radicals in Biology and Medicine. Clarendon Press, Oxford.
  • Irie Y., Saeki M., Kamisaki Y., Martin E. and Murad F. (2003) Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc. Natl Acad. Sci. USA 100, 56345639.
  • Iwamoto K., Kakiuchi C., Bundo M., Ikeda K. and Kato T. (2004) Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 9, 406416.
  • Iwamoto K., Bundo M. and Kato T. (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14, 241253.
  • Janssen R. J., Nijtmans L. G., van den Heuvel L. P. and Smeitink J. A. (2006) Mitochondrial complex I: structure, function and pathology. J. Inherit. Metab. Dis. 29, 499515.
  • Kato T. (2008) Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’? Trends Neurosci. 31, 495503.
  • Kimura H., Liu S., Yamada S., Uchida K., Matsumoto K., Mukaida M. and Yoshida, K.-i. (2005) Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte NADPH oxidase in early endo-toxemia. Free Radic. Res. 39, 845851.
  • King T. D. and Jope R. S. (2005) Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress. NeuroReport 16, 597601.
  • Kirsch M., Lehnig M., Korth H. G., Sustmann R. and de Groot H. (2001) Inhibition of peroxynitrite-induced nitration of tyrosine by glutathione in the presence of carbon dioxide through both radical repair and peroxynitrate formation. Chemistry 7, 33133320.
  • Konradi C., Eaton M., MacDonald M. L., Walsh J., Benes F. M. and Heckers S. (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61, 300308.
  • Konradi A. O., Rotar O. P., Korostovtseva L. S., Ivanenko V. V., Solntcev V. N., Anokhin S. B., Bart V. A. and Shlyakhto E. V. (2011) Prevalence of metabolic syndrome components in a population of bank employees from St. Petersburg, Russia. Metab. Syndr. Relat. Disord. 9, 337343.
  • Konradi C., Sillivan S. E. and Clay H. B. (2012) Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol. Dis. 45, 3747.
  • Lai J. S., Zhao C., Warsh J. J. and Li P. P. (2006) Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur. J. Pharmacol. 539, 1826.
  • Lenaz G. (2001) The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52, 159164.
  • Ly H. K., Utesch T., Díaz-Moreno I., García-Heredia J. M., De La Rosa M. A. and Hildebrandt P. (2012) Perturbation of the redox site structure of cytochrome c variants upon tyrosine nitration. J. Phys. Chem. B. [Epub ahead of print].
  • Mattson M. P. and Liu D. (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med. 2, 215231.
  • McCord J. M. and Fridovich I. (1988) Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 5, 363369.
  • Merikangas K. R., Jin R., He J. P. et al. (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 68, 241251.
  • Nakagawa H., Komai N., Takusagawa M., Miura Y., Toda T., Miyata N., Ozawa T. and Ikota N. (2007) Nitration of specific tyrosine residues of cytochrome C is associated with caspase-cascade inactivation. Biol. Pharm. Bull. 30, 1520.
  • Naoi M., Maruyama W., Shamoto-Nagai M., Yi H., Akao Y. and Tanaka M. (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol. Neurobiol. 31, 8193.
  • O'Brien J. S. and Sampson E. L. (1965) Myelin Membrane: a molecular abnormality. Science 150, 16131614.
  • Osoata G. O., Yamamura S., Ito M., Vuppusetty C., Adcock I. M., Barnes P. J. and Ito K. (2009) Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem. Biophys. Res. Commun. 384, 366371.
  • Power J. H. and Blumbergs P. C. (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol. 117, 6373.
  • Reeve A. K., Krishnan K. J. and Turnbull D. M. (2008) Age related mitochondrial degenerative disorders in humans. Biotechnol. J. 3, 750756.
  • Rosenfeld M., Brenner-Lavie H., Ari S. G., Kavushansky A. and Ben-Shachar D. (2011) Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol. Psychiatry 69, 980988.
  • Rydén E., Johansson C., Blennow K. and Landén M. (2009) Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. J. Neural Transm. 116, 16671674.
  • Schulze T. G., Akula N., Breuer R. et al. (2012) Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. World J. Biol. Psychiatry [Epub ahead of print].
  • Scola G., Kim H. K., Young L. T and Andreazza A. C. (2013) A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol. Psychiatry 73, e4e5.
  • Sies H. (1991) Oxidative stress: from basic research to clinical application. Am. J. Med. 91, 31S38S.
  • Sun X., Wang J. F., Tseng M. and Young L. T. (2006) Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J. Psychiatry Neurosci. 31, 189196.
  • Tan H. and Wang J. F. (2011) Lithium inhibits amphetamine-induced 4-hydroxynonenal-protein adductions in rat frontal cortex. Biol. Psychiatry 69, 223S224S.
  • Versace A., Andreazza A. C., Young L. T. et al. (2013) Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol. Psychiatry [Epub ahead of print].
  • Wang J. F. (2007) Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. Can. J. Psychiatry 52, 753762.
  • Wang J. F., Shao L., Sun X. and Young L.T. (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 11, 523529.
  • Williams L., Jacka F., Pasco J., Henry M., Dodd S., Nicholson G., Kotowicz M. and Berk M. (2010) The prevalence of mood and anxiety disorders in Australian women. Australas. Psychiatry 18, 250255.
  • Williams H. J., Norton N., Dwyer S. et al. (2011) Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 16, 429441.
  • Wong C. M., Marcocci L., Liu L. and Suzuki Y. J. (2010) Cell signaling by protein carbonylation and decarbonylation. Antioxid. Redox Signal. 12, 393404.
  • Yatham L. N., Liddle P. F., Lam R. W., Adam M. J., Solomons K., Chinnapalli M. and Ruth T. J. (2005) A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania. Bipolar Disord. 7(Suppl 5), 5357.